Literature DB >> 8560390

Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men.

Y Tabardel1, J Duchateau, D Schmartz, G Marécaux, M Shahla, L Barvais, J L Leclerc, J L Vincent.   

Abstract

BACKGROUND: Interleukin (IL)-10 is a potent antiinflammatory cytokine inhibiting the release of tumor necrosis factor--alpha (TNF-alpha) and IL-8 by activated macrophages and polymorphonuclear leukocytes. Cardiopulmonary bypass (CPB) represents a unique situation where an inflammatory reaction is predictably induced. The present study examined the influence of CPB on the release of TNF-alpha, IL-1 beta, IL-8, and IL-10 and also defined the effects of pretreatment with corticosteroids on the release of these cytokines.
METHODS: The study included 22 patients undergoing coronary artery bypass graft operations, including eight control patients and seven patients who received dexamethasone, and seven patients who received methylprednisolone 4 hours before the operation. Cytokines were measured with the enzyme-linked immunosorbent assay technique before treatment, before anesthesia induction, immediately before heparin administration, before aorta declamping, 10 minutes and 90 minutes after aorta declamping, and 4 hours after the end of CPB.
RESULTS: In the control patients the TNF-alpha levels and especially the IL-8 levels increased during CPB and reached their maximal levels 4 hours after CPB. IL-10 levels rose moderately and transiently, reaching peak values 90 minutes after aorta declamping. Notably, administration of corticosteroids prevented IL-8 release but increased IL-10 levels, which were tenfold higher than in the control group 90 minutes after aorta declamping (dexamethasone, 271 +/- 128 pg/ml; methylprednisolone, 312 +/- 213 pg/ml; control, 17 +/- 12 pg/ml, p < 0.05). IL-1 beta was not detected in any group of patients.
CONCLUSIONS: The present data indicate that IL-10 is released together with proinflammatory cytokines during and after CPB and that pretreatment with corticosteroids markedly enhances this release. The release of IL-10 may play an important role in the antiinflammatory effects of corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8560390     DOI: 10.1016/s0039-6060(96)80217-0

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  21 in total

1.  Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review.

Authors:  S Sauerland; M Nagelschmidt; P Mallmann; E A Neugebauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 2.  [Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis].

Authors:  G Hein; T Eidner; P Oelzner; B Manger
Journal:  Med Klin (Munich)       Date:  1999-10-15

3.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

4.  Expression and function of MIP-2 are reduced by dexamethasone treatment in vivo.

Authors:  R Schramm; Q Liu; H Thorlacius
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

5.  Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy.

Authors:  G Fingerle-Rowson; M Angstwurm; R Andreesen; H W Ziegler-Heitbrock
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

6.  Effects of preinjury administration of corticosteroids on pseudointimal hyperplasia and cytokine response in a rat model of balloon aortic injury.

Authors:  Kazuhito Nagasaki; Kenji Matsumoto; Munehisa Kaneda; Tsunehiro Shintani; Shintaro Shibutani; Takaya Murayama; Go Wakabayashi; Motohide Shimazu; Makio Mukai; Masaki Kitajima
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

Review 7.  [The importance of cytokines in the posttraumatic inflammatory reaction].

Authors:  F Hildebrand; H-C Pape; C Krettek
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

8.  Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity.

Authors:  Alexandre dos Santos Pyrrho; Juliene Antonio Ramos; Roberto Moura Neto; Célia Santos da Silva; Henrique Leonel Lenzi; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 9.  Remodeling of the immunoinflammatory network system in elderly cancer patients: implications of inflamm-aging and tumor-specific hyperinflammation.

Authors:  Chikao Miki; Masato Kusunoki; Yasuhiro Inoue; Keiichi Uchida; Yasuhiko Mohri; John A C Buckels; Paul McMaster
Journal:  Surg Today       Date:  2008-09-27       Impact factor: 2.549

Review 10.  Surgical trauma: hyperinflammation versus immunosuppression?

Authors:  Michael D Menger; Brigitte Vollmar
Journal:  Langenbecks Arch Surg       Date:  2004-05-28       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.